Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease

To evaluate the safety of adalimumab in pediatric patients who participated in clinical trials of juvenile idiopathic arthritis (polyarticular juvenile idiopathic arthritis and pediatric enthesitis-related arthritis), psoriasis, and Crohn's disease.

Source: The Journal of Pediatrics - July 25, 2018 Category: Pediatrics Authors: Gerd Horneff, Marieke M.B. Seyger, Dilek Arikan, Jasmina Kalabic, Jaclyn K. Anderson, Andreas Lazar, David A. Williams, Chen Wang, Rita Tarzynski-Potempa, Jeffrey S. Hyams Tags: Original Articles Source Type: research